v3.26.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   24,875,587    
Beginning balance at Dec. 31, 2024 $ (33,415) $ 2 $ 752,649 $ (786,066)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock (in shares)   108,072    
Issuance of common stock 139   139  
Stock-based compensation costs 529   529  
Voluntary surrender of shares by shareholder (in shares)   (301)    
Net loss (11,759)     (11,759)
Ending balance (in shares) at Mar. 31, 2025   24,983,358    
Ending balance at Mar. 31, 2025 (44,506) $ 2 753,317 (797,825)
Beginning balance (in shares) at Dec. 31, 2024   24,875,587    
Beginning balance at Dec. 31, 2024 (33,415) $ 2 752,649 (786,066)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (23,496)      
Ending balance (in shares) at Jun. 30, 2025   37,838,479    
Ending balance at Jun. 30, 2025 (15,259) $ 3 794,300 (809,562)
Beginning balance (in shares) at Mar. 31, 2025   24,983,358    
Beginning balance at Mar. 31, 2025 (44,506) $ 2 753,317 (797,825)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock (in shares)   12,500,000    
Issuance of common stock 40,349 $ 1 40,348  
Stock-based compensation costs 635   635  
Vesting of restricted stock units (in shares)   355,121    
Net loss (11,737)     (11,737)
Ending balance (in shares) at Jun. 30, 2025   37,838,479    
Ending balance at Jun. 30, 2025 $ (15,259) $ 3 794,300 (809,562)
Beginning balance (in shares) at Dec. 31, 2025 83,025,384 83,025,384    
Beginning balance at Dec. 31, 2025 $ 213,695 $ 8 1,040,417 (826,730)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Exercise of warrants (in shares)   8,206,833    
Exercise of warrants 43,458 $ 1 43,457  
Stock-based compensation costs 19,130   19,130  
Taxes withheld related to net share settlement of equity awards (4,197)   (4,197)  
Vesting of restricted stock units (in shares)   128,384    
Net loss (48,287)     (48,287)
Ending balance (in shares) at Mar. 31, 2026   91,360,601    
Ending balance at Mar. 31, 2026 $ 223,799 $ 9 1,098,807 (875,017)
Beginning balance (in shares) at Dec. 31, 2025 83,025,384 83,025,384    
Beginning balance at Dec. 31, 2025 $ 213,695 $ 8 1,040,417 (826,730)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss $ (69,037)      
Ending balance (in shares) at Jun. 30, 2026 93,130,394 93,130,394    
Ending balance at Jun. 30, 2026 $ 250,857 $ 9 1,146,615 (895,767)
Beginning balance (in shares) at Mar. 31, 2026   91,360,601    
Beginning balance at Mar. 31, 2026 223,799 $ 9 1,098,807 (875,017)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Exercise of warrants (in shares)   1,000    
Issuance of common stock (in shares)   1,476,538    
Issuance of common stock 35,753   35,753  
Exercise of warrants 4   4  
Stock-based compensation costs 13,036   13,036  
Taxes withheld related to net share settlement of equity awards (985)   (985)  
Vesting of restricted stock units (in shares)   292,255    
Net loss $ (20,750)     (20,750)
Ending balance (in shares) at Jun. 30, 2026 93,130,394 93,130,394    
Ending balance at Jun. 30, 2026 $ 250,857 $ 9 $ 1,146,615 $ (895,767)